Should the UK ban private companies from patenting publicly funded scientific discoveries?

Much of Britain's cutting-edge research is bankrolled by taxpayers through UKRI and university grants, yet private firms often reap the commercial rewards. Critics say the public pays twice; defenders argue patents are what turn ideas into products.

Anoniem stemmen is mogelijk. Registreer voor een profiel en score.